Synthesis, characterization and antitumor studies of Mn(II), Ni(II), Cu(II) and Zn(II) complexes of N-Nicotinoyl-N′-o-hydroxythiobenzhydrazide

BioMetals

Volumn 16, Issue 2, 2003, Pages 311-320

  Shrivastav, Anuraag ^a   Singh, Nand Kishore ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

3d metal complexes; Antitumor activity; N nicotinoyl N o hydroxythiobenzhydrazide

Indexed keywords

LIGAND; METAL COMPLEX; N NICOTINOYL N' 2 HYDROXYTHIOBENZHYDRAZIDE; N NICOTINOYL N' 2 HYDROXYTHIOBENZHYDRAZIDE COPPER; N NICOTINOYL N' 2 HYDROXYTHIOBENZHYDRAZIDE MANGANESE; N NICOTINOYL N' 2 HYDROXYTHIOBENZHYDRAZIDE NICKEL; N NICOTINOYL N' 2 HYDROXYTHIOBENZHYDRAZIDE ZINC; THIOSEMICARBAZIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; GROWTH INHIBITION; INBRED STRAIN; LYMPHOMA; MOUSE; NONHUMAN; SPLEEN CELL; SYNTHESIS; THYMOCYTE; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CELL LINE, TUMOR; COPPER; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HYDRAZINES; LYMPHOMA, T-CELL; MALE; MANGANESE; MICE; MICE, INBRED BALB C; NICKEL; ORGANOMETALLIC COMPOUNDS; SURVIVAL RATE; TUMOR CELLS, CULTURED; ZINC;

ANIMALIA;

EID: 0037409792     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020611428001     Document Type: Article

References (47)

1. Agrawal S, Singh NK, Aggarwal RC, Sodhi A, Tandon P. 1986 Synthesis, structure and antitumor activity of N-salicyloyl-N′-(2-furylthiocarbonyl)hydrazine and its copper(II) complex. J Med Chem 29, 199-202.
2. Ali MA, Livingstone SE. 1974 Metal complexes of sulfur-nitrogen chelating agents. Coord Chem Rev 13, 101-132.
3. Antholine WE, Knight JM, Petering DH. 1976 Some properties of copper and zinc complexes of 2-formylpyridine thiosemicarbazone. J Med Chem 19, 339-341.
4. Blanz EJ, French FA, DoAmaral JR, French DA. 1970 Carcinostatic activity of thiosemicarbazones of formylheteroaromatic compounds VII: 2-formylpyridine derivatives bearing additional ring substituents. J Med Chem 13, 1124-1130.
5. Campbell MJM. 1975 Transition metal compounds of thiosemicarbazide and thiosemicarbazones. Coord Chem Rev 15, 279-.
6. Das M, Livingstone SE. 1978 Cytotoxic action of some transition metal chelates of schiff bases derived from 5-methyldithiocarbazates. Br J Cancer 37, 466-469.
7. Dave LD Thampy SK, Shelat YA. 1981 Antimicrobial activity of o-hydroxythiosemicarbazones and their Ni(II), Cu(II) and Co(II) chelates. J Institution Of Chemists (India) 53, 169-172; 237-241.
8. Deckers PJ, Davis RC, Parker GA, Mannick JA. 1973 The effect of tumor on concomitant tumor immunity. Cancer Res 33, 33-39.
9. Easmon J, Purstinger G, Heinisch G, Roth T, Fiebig HH, Holzer W, Jager W, Jenny M, Hofmann J. 2001 Synthesis, cytoxicity and antitumor activity of copper(II) and iron(II) complexes of (4)N-azabicyclo[3.2.2]nonane thiosemicarbazones derived from acyl diazines. J Med Chem 44, 2164-2171.
10. Eastmen A. 1990 Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2, 275-280.
11. French FA, Blanz EJ, Shaddix SC, Brockman RW. 1974 Alpha-N-formylheteroaromatic thiosemicarbazones. Inhibition of tumor derived ribonucleoside diphosphate reductase and correlation with in vivo antitumor activity. J Med Chem 17, 172-181.
12. Gabel J, Lassen E, Trinderup P. 1977 Nickel(II) complexes of thiohydrazonates. Acta Chem Scand 31, 657-665.
13. Geetharani K, Sathyanarayana DN. 1977 metal complexes of thiosemicarbazides: vibrational analysis of Ni(II) thiosemicarbazide complexes and their deutero isotopomers. Austr J Chem 30, 1617-.
14. Hardy CL, Balducci L. 1985 Hemopoietic alterations of cancer. Amer J Med Sci 290, 196-205.
15. th ed.
16. Kleinerman ES, Zwelling LA, Muchmore AV. 1980 Enhancement of naturally occurring human spontaneous monocyte mediated cytotoxicity by cis-diaminedichloroplatnum(II). Cancer Res 40, 3099-3102.
17. Kumar A, Singh SM. 1995 Effect of cisplatin-administration on the proliferation and differentiation of bone marrow cells of tumor bearing mice. Immunol Cell Biol 73, 220-225.
18. Lever ABP. 1984 'Inorganic Electronic Spectroscopy,' 2nd Edn. Elsevier, Amsterdam.
19. Levison W, Helling R. 1976 'Antitumor Agents and Chemotherapy', 9, 160-.
20. Lichtenstein AK, Pende D. 1986 Enhancement of natural killer cytotoxicity by cis-diamminedichloroplatnum(II) in vivo and in vitro. Cancer Res 46, 639-644.
21. Liu MC, Lin TS, Sartorelli AC. 1992 Synthesis and antitumor activity of amino deivatives of pyridine-2-carboxaldehydethiosemicarbazone. J Med Chem 20, 3672-3677.
22. + T-Cells. J Immunol 149, 949-956.
23. Minkel DT, Petering DH. 1978 Initial reaction of 3-ethoxy-2-oxobutyraldehyde bis(thiosemicarbazonato)copper(II) with Ehrlich ascites tumor cells. Cancer Res 38, 117-123.
24. Minkel DT, Saryan LA, Petering DH. 1978 Structure-function correlation in the reaction of bis(thiosemicarbazonato)copper(II) complexes with Ehrlich ascites tumor cells. Cancer Res 38, 124-129.
25. Mossmann TR, Cherwinski H, Bond MV, Giedliv MA, Coffmann R. 1986 Two types of murine helper T-cell clones. I. Definition according to profiles of lymphokine activities and secreted protiens J Immunol 13, 2348-2357.
26. Ogura T, Shindo H, Shinzato O, Namba M, Yamamura Y. 1982 In vitro tumor cell killing by peritoneal macrophages from mitomycin c treated rats. Cancer Immunol Immunother 13, 112-117.
27. Oubrahim H, Stadtman ER, Chock PB. 2001 Mitochondria play no roles in Mn(II)-induced apoptosis in HeLa cells. Proc Natl Acad Sci USA 98, 9505-9510.
28. Parajuli P, Singh SM, Kumar A. 1995 Effect of cisplatin and FK-565 on the activation of tumor associated bone marrow derived macrophages by Dalton's lymphoma. Int J Immunopharmac 17, 1-7.
29. Ranjan P, Sodhi A, Singh SM. 1998 Murine peritoneal macrophages treated with cisplatin and interferron-gamma undergo NO-mediated apoptosis via activation of endonucleases. Anticancer Drugs 9, 333-342.
30. Rosenberg B. 1985 Fundamenta studies with cisplatin. Cancer 55, 2303-2316.
31. Satorelli AC, Agrawal KC, Mooney PD. 1976 Potential antitumor agents. 13. 4-Methyl-5-amino-1-formyl isoquinoline thiosemicarbazone. J Med Chem 19, 970-972.
32. Sellins KS, Cohen JJ. 1987 Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139, 3199-3206.
33. Shanker A, Singh SM, Sodhi A. 2000 Ascitic growth of a transplantable T-cell lymphoma of spontaneous origin induces thymic involution: induction of apoptosis in thymocytes. Tumor Biol 21, 315-327.
34. Shanker A, Singh SM. 2000 Characterization of factors inducing apoptosis in thymocytes of mice bearing a transplantable T-cell lymphoma of spontaneous origin. Neoplasma 47, 90-95.
35. Shrivastav A, Singh NK, Singh SM. 2002 Synthesis, characterization and antitumor studies of Mn(II), Fe(III), Co(II), Ni(II), Cu(II) and Zn(II) complexes of N-salicyloyl-N′-o-hydroxythiobenzhydrazide. Bioorg Med Chem 10, 887-895.
36. Singh M, Yadav LDS, Mishra SBS. 1981 Studies on some antifungal transition metal chelates of N-(5-phenyl-1,3,4-thiadiazole-2-yl)dithiocarbamic acid. J Inorg Nucl Chem 43, 1701-1706.
37. Singh NK, Agrawal N, Aggarwal RC. 1984 Synthesis, characterization and antibacterial studies of Fe(II), Co(II), Cu(II) and Zn(II) complexes of pyridine-4-carboxaldehyde isonicotinoyl hydrazone. Ind J Chem 23A, 1011-1015.
38. Singh NK, Agrawal N, Aggarwal RC. 1986 Synthetic and physicochemical studies on Co(II), Ni(II), Cu(II) and Zn(II) complexes of pyridine-4-carboxaldehyde thioisonicotinoyl hydrazone. Synth React Inorg Met-Org Chem 16, 361-376.
39. Singh NK, Singh N, Prasad GC. 1996 Complexes of N-aroyl-N′-thiobenzhydrazide with Co(II), Ni(II) and Zn(II). Transition Met Chem 21, 296-299.
40. Singh NK, Singh N, Prasad GC, Sodhi A, Shrivastava A. 1996 Synthesis, characterization and antitumor studies on N-salicyloyl-N′-thiobenzhydrazide and its Copper(II) complex. Transition Met Chem 21, 556-559.
41. Singh NK, Singh N, Prasad GC, Sodhi A, Shrivastava A. 1997 Antiutumor activity studies of newly synthesized N-salicyloyl-N′-(p-hydroxybenzthioyl)hydrazine and its copper(II) complex both in vivo and in vitro. Bioorg Med Chem 5, 245-251.
42. Singh NK, Shrivastava A, Thomas MJK. 1999 Synthesis and spectroscopic characterization of binary and mixed ligand complexes of N-furoyl-N′-thiobenzhydrazide with some 3d-metal ions. Synth React Inorg Met-Org Chem 29, 1427-1449.
43. Singh SM, Parajuli P, Shrivastava A, Sodhi A. 1997 Alteration in immune response by tumor cells: underlying mechanisms. Int J Immunopathol Pharmacol 1, 27-35.
44. Valdes-Martinez J, Toscano RA, Zenstella Deheasa A, Salberg MM, Bain GA, West DX. 1996 Synthesis, crystal and molecular structure of 5-bromo-salicylaldehyde-2-methylthiosemicarbazonato(nitrato)copper(II) monohydrate. Polyhedron 15, 427-431.
45. West DX, Bain GA, Butcher RJ, Jasinski JP, Pozdniakiv RY, Valdis-Martinez J, Toscano RA, Ortega SH. 1996 Strctural studies of three isomeric forms of heterocyclic N(4) substituted thiosemicarbazones and two Ni(II) complexes. Polyhedron 15, 665-674.
46. 4N-dialkyl-thiosemicarbazones, relation to their spectral, magnetic and biological properties. Structure and Bonding 76, 1-50.
47. 4N-methyl, -dimethyl,-diethyl and -dipropylthiosemicarbazones. Transition Met Chem 17, 568-572.